Visually discernible [18F]fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: A potential new risk factor

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 7, 2010, Pages 3182-3188

  Yun, Mijin ^a,b   Noh, Tae Woong ^a   Cho, Arthur ^a   Choi, Yun Jung ^a   Hong, Soon Won ^a   Park, Cheong Soo ^a   Lee, Jong Doo ^a   Kim, Chun K ^b  

^a Yonsei University College of Medicine   (South Korea)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; MIDDLE AGED; PAPILLARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REGRESSION ANALYSIS; SCINTISCANNING; THYROID TUMOR;

ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS;

EID: 77954890772     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2091     Document Type: Article

References (29)

1. Cappelli C, Castellano M, Braga M, Gandossi E, Pirola I, De Martino E, Agosti B, Rosei EA 2007 Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J Surg Oncol 95:555-560 (Pubitemid 47164661)
2. Roti E, degli Uberti EC, Bondanelli M, Braverman LE 2008 Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659-673
3. Kim TY, Hong SJ, Kim JM, Gu Kim W, Gong G, Ryu JS, Kim WB, Yun SC, Shong YK 2008 Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer 8:296
4. Jeong HS, Chung M, Baek CH, Ko YH, Choi JY, Son YI 2006 Can [18F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas? Laryngoscope 116:2133-2137
5. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y 2003 Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399-407 (Pubitemid 38176456)
6. Noguchi S, Yamashita H, Uchino S, Watanabe S 2008 Papillary microcarcinoma. World J Surg 32:747-753
7. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH 2003 Papillary microcarcinoma of the thyroid: prognostic significance of lymph node metastasis and multifocality. Cancer 98:31-40 (Pubitemid 36741122)
8. Pearce EN, Braverman LE 2004 Papillary thyroid microcarcinoma outcomes and implications for treatment. J Clin Endocrinol Metab 89:3710-3712 (Pubitemid 39071461)
9. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
10. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM 1985 Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62:816-822 (Pubitemid 15009404)
11. Vansteenkiste J, Fischer BM, Dooms C, Mortensen J 2004 Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol 5:531-540 (Pubitemid 39194041)
12. Eubank WB, Mankoff DA 2005 Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med 35:84-99 (Pubitemid 40568742)
13. Kim CK, Alavi JB, Alavi A, Reivich M 1991 New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol 10:85-91
14. Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM 2008 Histopathologic characterization of radioactive iodinerefractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer 113:48-56
15. Wang W, Larson SM, Fazzari M, Tickoo SK, Kolbert K, Sgouros G, Yeung H, Macapinlac H, Rosai J, Robbins RJ 2000 Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85:1107-1113
16. Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W 1996 Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37:1468-1472
17. Mitchell JC, Grant F, Evenson AR, Parker JA, Hasselgren PO, Parangi S 2005 Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery 138:1166-1174; discussion 1174-1165
18. Robbins KT, Shaha AR, Medina JE, Califano JA, Wolf GT, Ferlito A, Som PM, Day TA 2008 Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134:536-538
19. Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A 2007 Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 31:2085-2091
20. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C, Schlumberger M 1998 Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83:553-559
21. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ 1992 Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139-1147
22. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A 2004 Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89:3713-3720
23. Besic N, Pilko G, Petric R, Hocevar M, Zgajnar J 2008 Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol 97:221-225
24. Lim DJ, Baek KH, Lee YS, Park WC, Kim MK, Kang MI, Jeon HM, Lee JM, Yun-Cha B, Lee KW, Son HY, Kang SK 2007 Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid 17:883-888
25. Min HS, Choe G, Kim SW, Park YJ, Park do J, Youn YK, Park SH, Cho BY, Park SY 2008 S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid. Mod Pathol 21:748-755
26. Roh JL, Kim JM, Park CI 2008 Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol 15:2482-2486
27. Srinivas SM, Dhurairaj T, Basu S, Bural G, Surti S, Alavi A 2009 A recovery coefficient method for partial volume correction of PET images. Ann Nucl Med 23:341-348
28. Kim SC, Machac J, Krynyckyi BR, Knesaurek K, Krellenstein D, Schultz B, Gribetz A, DePalo L, Teirstein A, Kim CK 2008 Fluorodeoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: Assigning a probability of malignancy may be preferable to binary readings. Ann Nucl Med 22:165-170
29. Rousset OG, Ma Y, Evans AC 1998 Correction for partial volume effects in PET: principle and validation. J Nucl Med 39:904-911